The stakes are high for psilocybin clinical trials — there’s a pressing need for a more effective medical solution in the fight against depression, especially treatment-resistant depression.
Buenos Aires, Argentina - October 23, 2024 Two doses of psilocybin, the active ingredient in “magic mushrooms,” is the drug that produces the best result after six months in the battle against ...